Mitchell Shirvan
CSO and CDO at Silexion Therapeutics Corp (SLXN)
Mitchell Shirvan has filed 3 insider reports with the SEC since February 2026, as CSO and CDO at Silexion Therapeutics Corp (SLXN). In the last 12 months Mitchell Shirvan sold $31K of stock on the open market. The latest filing, on June 8, 2026, reports grant or award at Silexion Therapeutics Corp (SLXN).
- Filings
- 3
- Companies
- 1
- Bought on market
- None
- Sold on market
- $31K
Companies where Mitchell Shirvan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| CSO and CDO | 8,789 | $31K | $1.31 | Jun 8, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 4, 2026SLXNCSO and CDO Shirvan Mitchell was granted 6,000 units of Ordinary Shares, increasing direct ownership by 215% to 8,789 unitsForm 4Grant or award
- Mar 26, 2026-$31KSLXNSEC Form 4 filed by Shirvan MitchellForm 4Open-market sale
- Feb 20, 2026SLXNCSO and CDO Shirvan Mitchell was granted 49,726 units of Ordinary Shares, increasing direct ownership by 5,069% to 50,707 unitsForm 4Grant or award
Compare Mitchell Shirvan with
- Mitchell Shirvan vs Hadar Mirit Horenshtein1 shared
- Mitchell Shirvan vs Ilan Hadar1 shared
- Mitchell Shirvan vs Shlomo Noy1 shared
- Mitchell Shirvan vs Ruth Alon1 shared
- Mitchell Shirvan vs Dror Yosef Abramov1 shared
- Mitchell Shirvan vs Amnon Peled1 shared
Other insiders at the same companies
- Hadar Mirit HorenshteinSLXN
- Ilan HadarSLXN
- Shlomo NoySLXN
- Ruth AlonSLXN
- Dror Yosef AbramovSLXN
- Amnon PeledSLXN
- Avner LushiSLXN
- Ilan LevinSLXN
Questions about Mitchell Shirvan
- What is Mitchell Shirvan's role at Silexion Therapeutics Corp?
- Mitchell Shirvan reports to the SEC as CSO and CDO at Silexion Therapeutics Corp (SLXN), according to the latest filing on June 8, 2026.
- How many shares does Mitchell Shirvan own?
- After the latest filing that states it, Mitchell Shirvan directly owned 8,789 shares of Silexion Therapeutics Corp (SLXN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mitchell Shirvan bought or sold stock recently?
- The most recent open-market sale was on March 26, 2026: sold 22,818 shares of Silexion Therapeutics Corp (SLXN) for $31K at an average of $1.36.
- How do I get alerts when Mitchell Shirvan files?
- Follow Mitchell Shirvan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Mitchell Shirvan (SEC CIK 0001727789). Totals count each trade once, skipping amendments whose original is on file, from Feb 23, 2026 on. View on SEC EDGAR · Get this as JSON